Other
Real-World Study
0
Pipeline Programs↗
13
Active Trials↗
5
Companies Involved↗
Real-world Study is an early-stage landscape with 0 programs across 5 companies. The most active players are Biogen, Innovent Biologics (Suzhou) Co. Ltd., Boehringer Ingelheim.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
24
clinical trials
Unknown status7 · 29%
Recruiting6 · 25%
Not yet recruiting5 · 21%
Active, not recruiting2 · 8%
Completed2 · 8%
Terminated2 · 8%
Clinical Trials
Trial Activity
24 trials
Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study
Recruiting·—·Phase 4·NCT07410039·200 enrolled
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
Recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 1·NCT07319364·90 enrolled
A Real-world Study of Trifluridine/Tipiracil Containing Regimen for the Treatment of Patients With mCRC (REFLECT Study)
Not yet recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·N/A·NCT06195111·200 enrolled
Real-world Study on Adjuvant Octreotide Therapy in pNETs
Completed·—·N/A·NCT06080204·411 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)